CEFTRIAXON Labatec subst sèche 1 g flac 10 pce
7680598760031
CH-59876
J01DD04
08.01.3.
Reimbursement limitations:
ROCEPHIN2
• Traitement ultérieur dans la pratique ambulatoire de l'ostéomyélite, des abscès pulmonaires et de l'endocardite.
…
1 / 3
google
Details
- Product number
- 5987603
- CPT
- -
- Packaging group
- 10 x 1
- Unit
- g
- Composition
- Praeparatio sicca: ceftriaxonum 1000 mg ut ceftriaxonum natricum corresp. natrium 83 mg, pro vitro.
Articles (1)
Ceftriaxon Labatec 1 g i.v./i.m., poudre pour solution injectable
poudre pour solution injectable
10 x 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
1000.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
83.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 73.25
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2020
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59876
- Drug name
- Ceftriaxon Labatec, poudre pour solution injectable/pour perfusion
- Galenic form
- PULPA
- ATC Code
- J01DD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/02/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CEFTRIAXON Labatec subst sèche 1 g flac 10 pce
- Description (DE)
- CEFTRIAXON Labatec Trockensub 1 g Durchstf 10 Stk
- Market launch
- 25/02/2010
- Narcotic (BTM)
- No
Original drug
Rocephin, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
GTIN:
7680446250011
CHF 21.05